文章來源:中國(guo)電子信息產業集團有限公司 發布時間:2021-05-14
近(jin)日,中(zhong)(zhong)國(guo)電子旗下中(zhong)(zhong)國(guo)電子系統工(gong)程第四建(jian)設(she)有限公(gong)司(si)(以(yi)下簡稱“中(zhong)(zhong)電四公(gong)司(si)”)承建(jian)的(de)(de)國(guo)內(nei)(nei)首家(jia)人用P3(三(san)級生(sheng)(sheng)(sheng)物安全水平)生(sheng)(sheng)(sheng)物醫藥生(sheng)(sheng)(sheng)產車(che)間(jian)項目順利(li)完成(cheng)交(jiao)付。該項目的(de)(de)建(jian)成(cheng),標(biao)志著全球最大(da)(da)新冠疫(yi)(yi)苗(miao)生(sheng)(sheng)(sheng)產車(che)間(jian)誕生(sheng)(sheng)(sheng),量產后(hou)年產能(neng)達1億劑,具備滿足大(da)(da)規(gui)模緊急使用和常(chang)規(gui)接種的(de)(de)生(sheng)(sheng)(sheng)產條(tiao)件。在國(guo)內(nei)(nei)目前尚無針對人用疫(yi)(yi)苗(miao)的(de)(de)高級別生(sheng)(sheng)(sheng)物安全生(sheng)(sheng)(sheng)產車(che)間(jian)的(de)(de)建(jian)設(she)標(biao)準背景下,該項目的(de)(de)建(jian)成(cheng)還填補了國(guo)內(nei)(nei)重(zhong)大(da)(da)疫(yi)(yi)病防控在疫(yi)(yi)苗(miao)領域的(de)(de)生(sheng)(sheng)(sheng)物安全空(kong)白,對新冠肺炎疫(yi)(yi)情的(de)(de)藥品和疫(yi)(yi)苗(miao)研發意義重(zhong)大(da)(da)。
新(xin)冠(guan)肺炎疫情暴(bao)發后(hou),我國(guo)第一時間(jian)啟動全(quan)(quan)病毒(du)滅活疫苗的研發和生(sheng)產工作。中電四公司自春節期間(jian)開(kai)始,陸(lu)續(xu)承擔了(le)多個國(guo)內首批(pi)全(quan)(quan)病毒(du)滅活苗高(gao)級(ji)別生(sheng)物安全(quan)(quan)疫苗生(sheng)產車(che)間(jian)的總承包建(jian)設工作。

作為國內首家人用(yong)P3生物(wu)醫藥生產車(che)間(jian)項(xiang)目(mu)施工(gong)(gong)(gong)總包方,中(zhong)電(dian)四(si)公(gong)司負責鋼結構(gou)、土(tu)建及(ji)室外管廊、彩板裝修、暖通工(gong)(gong)(gong)程(cheng)(cheng)、室內管道(dao)、電(dian)氣(qi)、弱(ruo)電(dian)及(ji)自控、工(gong)(gong)(gong)藝設備的(de)二次(ci)配(pei)管、公(gong)用(yong)工(gong)(gong)(gong)程(cheng)(cheng)設備、空(kong)調自控及(ji)EMS工(gong)(gong)(gong)程(cheng)(cheng),水分配(pei)系統等,并從2月6日項(xiang)目(mu)啟動到4月15日車(che)間(jian)整(zheng)體交接(jie),始終全力以(yi)赴、精益求精,高(gao)質量完成了(le)新冠疫苗生產車(che)間(jian)的(de)建設工(gong)(gong)(gong)作。

施(shi)(shi)工(gong)(gong)(gong)過程(cheng)中(zhong),各專(zhuan)業(ye)系統繁多、工(gong)(gong)(gong)期(qi)(qi)緊(jin),進(jin)度把控(kong)是個重難(nan)點。為順(shun)利(li)(li)完成(cheng)施(shi)(shi)工(gong)(gong)(gong),項(xiang)(xiang)目(mu)團隊多次組織專(zhuan)項(xiang)(xiang)搶工(gong)(gong)(gong)會議,有序(xu)排定工(gong)(gong)(gong)序(xu),24小時連續作(zuo)業(ye),在(zai)物資采購、施(shi)(shi)工(gong)(gong)(gong)方案、作(zuo)業(ye)工(gong)(gong)(gong)序(xu)、疫情(qing)防(fang)護等方面克服(fu)種種困難(nan),僅(jin)用(yong)不到25天,順(shun)利(li)(li)完成(cheng)安裝工(gong)(gong)(gong)作(zuo)。同時,在(zai)項(xiang)(xiang)目(mu)初(chu)期(qi)(qi),項(xiang)(xiang)目(mu)部(bu)迅(xun)速組織成(cheng)立項(xiang)(xiang)目(mu)部(bu)疫情(qing)防(fang)控(kong)小組,高效(xiao)與當(dang)地政府和(he)業(ye)主單位快(kuai)速對(dui)接,制定疫情(qing)期(qi)(qi)間防(fang)控(kong)工(gong)(gong)(gong)作(zuo)方案及應急處置方案,對(dui)現場所有人員進(jin)行實名制管控(kong),減(jian)少人員聚(ju)集,杜絕未(wei)備(bei)案人員進(jin)入(ru)施(shi)(shi)工(gong)(gong)(gong)現場。
“新冠(guan)疫苗的(de)進展一(yi)直備受(shou)關(guan)注,作為滅活疫苗生產(chan)的(de)重(zhong)要環節之(zhi)一(yi),新冠(guan)疫苗生產(chan)車間的(de)建(jian)設關(guan)系重(zhong)大(da)。能(neng)順(shun)利建(jian)成此次項目(mu),我感到特別(bie)榮幸與自豪!”項目(mu)交付后,項目(mu)負責人(ren)高騰飛激(ji)動地說道。
目(mu)前,中電四公司在(zai)國(guo)(guo)際醫藥(yao)企業TOP20工(gong)(gong)程建設市場(chang)占有(you)率超(chao)過(guo)80%、國(guo)(guo)內(nei)醫藥(yao)企業TOP20工(gong)(gong)程建設市場(chang)占有(you)率超(chao)過(guo)50%、高(gao)等級(ji)P3動物生物安全實驗室(shi)工(gong)(gong)程建設市場(chang)占有(you)率超(chao)過(guo)50%,在(zai)全國(guo)(guo)各(ge)地已建或(huo)在(zai)建的生物制(zhi)藥(yao)相關項目(mu)(疫苗(miao)、血液(ye)制(zhi)品、單抗、細胞治療、胰島素等)等80余個。
【責(ze)任編輯:趙(zhao)藝涵】